STRAGEN NORDIC A/S: Financial statements 2022
CVR: 26717825
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 17,270,850 and a net result of DKK -3,257,245 compared with DKK 254,656 the year before. That is an increase of 298.7% compared with the year before. Equity in the 2022 report amounted to DKK 6,709,469. The solvency ratio was 21.3%.
- Gross Profit
- DKK 17,270,850
- Profit/Loss
- DKK -3,257,245
- Equity
- DKK 6,709,469
- Total Assets
- DKK 31,542,514
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 17.3M | -3.3M | 6.7M | 0 |
| 2021 | - | 4.3M | 255K | 10M | 6 |
| 2020 | - | 6.8M | 2.6M | 9.7M | 6 |
| 2019 | - | 7M | 1.7M | 7.1M | 6 |
| 2018 | - | 5.5M | 1.9M | 5.4M | - |
Official annual report
Keep an eye on STRAGEN NORDIC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 21, 2022, Anne Franch Nyquist-Hansen has joined the board of directors of STRAGEN NORDIC A/S.
As of December 21, 2022, Antoine Tétard has left the board of directors of STRAGEN NORDIC A/S.
As of December 21, 2022, Anne Franch Nyquist-Hansen is registered as adm. dir. of STRAGEN NORDIC A/S.
As of December 21, 2022, Nicholas Stopford is registered as suppleant of STRAGEN NORDIC A/S.
As of December 21, 2022, Antoine Tétard has stepped down as adm. dir. of STRAGEN NORDIC A/S.
As of December 20, 2022, Anne Franch Nyquist-Hansen has stepped down as suppleant of STRAGEN NORDIC A/S.
As of October 25, 2022, Nicholas Stopford has joined the board of directors of STRAGEN NORDIC A/S.
As of October 25, 2022, Michele Mencarelli has left the board of directors of STRAGEN NORDIC A/S.
As of July 1, 2022, Frank Bouisset has joined the board of directors of STRAGEN NORDIC A/S.
As of July 1, 2022, Amine Achite-Henni has left the board of directors of STRAGEN NORDIC A/S.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.
